Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cambridge Research Biochemicals

Cambridge Research Biochemicals?uq=UG6efJS6
1980 FOUNDED
M&A STATUS
51-60 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Manufacturer of peptides and polyclonal antibodies created for drug discovery and disease research applications. The company's antibodies include bio-active, search bio-active, stable labeled and search stable labeled peptides, enabling pharmaceutical, biotechnology and research institutes to enhance their research and development process for fighting against bacteria and virus.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 17-18 Belasis Court
  • Belasis Hall Technology Park
  • Billingham TS23 4AZ
  • England

+44 01642 000000

Cambridge Research Biochemicals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Cambridge Research Biochemicals‘s full profile, request access.

Request full access to PitchBook

Cambridge Research Biochemicals Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Cambridge Research Biochemicals‘s full profile, request access.

Request full access to PitchBook

Cambridge Research Biochemicals Executive Team (1)

Name Title Board
Seat
Contact
Info
Ken Liddle Founder